Search Results
Search for other papers by T V Novoselova in
Google Scholar
PubMed
Search for other papers by R Larder in
Google Scholar
PubMed
Search for other papers by D Rimmington in
Google Scholar
PubMed
Search for other papers by C Lelliott in
Google Scholar
PubMed
Search for other papers by E H Wynn in
Google Scholar
PubMed
Search for other papers by R J Gorrigan in
Google Scholar
PubMed
Search for other papers by P H Tate in
Google Scholar
PubMed
Search for other papers by L Guasti in
Google Scholar
PubMed
Search for other papers by The Sanger Mouse Genetics Project in
Google Scholar
PubMed
Search for other papers by S O’Rahilly in
Google Scholar
PubMed
Search for other papers by A J L Clark in
Google Scholar
PubMed
Search for other papers by D W Logan in
Google Scholar
PubMed
Search for other papers by A P Coll in
Google Scholar
PubMed
Search for other papers by L F Chan in
Google Scholar
PubMed
Introduction Melanocortin receptor accessory protein (MRAP) and its paralogue MRAP2 are a recently identified class of small, single-pass transmembrane domain accessory proteins ( Chan et al . 2009 , Novoselova et al . 2013 ). Both MRAP and
Search for other papers by Nadia Schoenmakers in
Google Scholar
PubMed
Search for other papers by Kyriaki S Alatzoglou in
Google Scholar
PubMed
Search for other papers by V Krishna Chatterjee in
Google Scholar
PubMed
Search for other papers by Mehul T Dattani in
Google Scholar
PubMed
Diagramatic representation of the hypothalamic–pituitary–thyroid axis with positive regulation (black) predominantly mediated by thyrotropin-releasing hormone (TRH) and negative (grey) feedback influences, predominantly mediated by thyroid hormone receptor (TR
Search for other papers by Pauline Campos in
Google Scholar
PubMed
EPSRC Centre for Predictive Modelling in Healthcare, University of Exeter, Exeter, UK
Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK
Search for other papers by Jamie J Walker in
Google Scholar
PubMed
Search for other papers by Patrice Mollard in
Google Scholar
PubMed
trigger large and rapid calcium (Ca 2+ ) influx through voltage-gated channels. AP firing can therefore be assessed by measuring changes in concentrations of intracellular Ca 2+ ( Yasuda et al. 2004 ). Similarly, activation of neurotransmitter receptors
Search for other papers by J Fahrenkrug in
Google Scholar
PubMed
Search for other papers by B Georg in
Google Scholar
PubMed
Search for other papers by J Hannibal in
Google Scholar
PubMed
Search for other papers by H L Jørgensen in
Google Scholar
PubMed
established ( Rookh et al . 1979 , Jordan et al . 1980 , Ottenweller & Hedge 1982 , Wong et al . 1983 , Kalsbeek et al . 2000 , Guo et al . 2015 ). Nerve fibres originating in the SCN innervating thyroid-releasing hormone (TRH) neurons in the
Centre for Neuroendocrinology and Department of Anatomy, Maurice Wilkins Centre for Molecular Biodiscovery, University of Otago, PO Box 913, Dunedin 9054, New Zealand
Search for other papers by David R Grattan in
Google Scholar
PubMed
the portal blood accounted for changes in prolactin secretion in various physiological conditions ( Ben-Jonathan et al . 1977 , 1980 , Gibbs & Neill 1978 , De Greef & Neill 1979 ). Dopamine receptors were identified on lactotroph cells in the
Search for other papers by Shona Wood in
Google Scholar
PubMed
Search for other papers by Andrew Loudon in
Google Scholar
PubMed
β sub-units of thyroid-stimulating hormone (TSH). These cells lack receptors for the hypothalamic thyrotropin-releasing hormone (TRH) ( Bockmann et al . 1997 ), and do not respond to conventional hypothalamic outputs. In mammals, the MT1 receptor co
Search for other papers by Alvaro Souto Padron in
Google Scholar
PubMed
Laboratório de Fisiologia Endócrina Doris Rosenthal, Laboratório de Biologia do Exercício, Instituto de Biofísica Carlos Chagas Filho and Instituto de Pesquisa Translacional em Saúde e Ambiente na Região Amazônica (INPeTAM), CCS-Bloco G- Cidade Universitria, Ilha do Fundo, Rio de Janeiro 21949-900, Brazil
Search for other papers by Ruy Andrade Louzada Neto in
Google Scholar
PubMed
Search for other papers by Thiago Urgal Pantaleão in
Google Scholar
PubMed
Search for other papers by Maria Carolina de Souza dos Santos in
Google Scholar
PubMed
Search for other papers by Renata Lopes Araujo in
Google Scholar
PubMed
Search for other papers by Bruno Moulin de Andrade in
Google Scholar
PubMed
Search for other papers by Monique da Silva Leandro in
Google Scholar
PubMed
Search for other papers by João Pedro Saar Werneck de Castro in
Google Scholar
PubMed
Search for other papers by Andrea Claudia Freitas Ferreira in
Google Scholar
PubMed
Search for other papers by Denise Pires de Carvalho in
Google Scholar
PubMed
TSH regulation, strongly support the hypothesis that 3,5-T2 functions as an agonist of the β isoform of thyroid hormone receptor (TR) in vivo . Figure 4 Type 1 (D1) and type 2 (D2) iodothyronine deiodinase activities in control rats and rats treated
Search for other papers by Dominik Simon Botermann in
Google Scholar
PubMed
Search for other papers by Nadine Brandes in
Google Scholar
PubMed
Search for other papers by Anke Frommhold in
Google Scholar
PubMed
Search for other papers by Ina Heß in
Google Scholar
PubMed
Search for other papers by Alexander Wolff in
Google Scholar
PubMed
Search for other papers by Arne Zibat in
Google Scholar
PubMed
Search for other papers by Heidi Hahn in
Google Scholar
PubMed
Search for other papers by Rolf Buslei in
Google Scholar
PubMed
Search for other papers by Anja Uhmann in
Google Scholar
PubMed
binding of Hh ligands (e.g. mammalian Sonic, Indian or Desert Hh) to the receptor protein Patched1 (Ptch). This releases the inhibition of Smoothened (Smo), which results in translocation of Smo into the primary cilium and nuclear translocation of
Search for other papers by Graham W Aberdeen in
Google Scholar
PubMed
Search for other papers by Jeffery S Babischkin in
Google Scholar
PubMed
Search for other papers by Gerald J Pepe in
Google Scholar
PubMed
Search for other papers by Eugene D Albrecht in
Google Scholar
PubMed
levels or action of estrogen are curtailed or reduced during human pregnancy, e.g. preterm birth, aromatase gene mutation, or endocrine disruptors that interfere with estrogen receptor action, lead to T2DM in offspring ( Hofman et al. 2004